We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$10.1M
Cap. Flow
-$33.9M
Cap. Flow %
-15.93%
Top 10 Hldgs %
56.92%
Holding
158
New
43
Increased
25
Reduced
16
Closed
45

Top Buys

Rank Stock Value
1
MGI
MoneyGram International, Inc. New
MGI
+$2.1M
2
ALR
Alere Inc
ALR
+$1.95M
3
PNRA
Panera Bread Co
PNRA
+$1.81M
4
KATE
Kate Spade & Company
KATE
+$1.6M
5
KCG
KCG Holdings, Inc.
KCG
+$1.55M

Top Sells

Rank Stock Value
1
MJN
Mead Johnson Nutrition Company
MJN
+$3.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.35M
3
UNH icon
UnitedHealth
UNH
+$2.29M
4
WWAV
The WhiteWave Foods Company
WWAV
+$1.85M
5
SYT
Syngenta Ag
SYT
+$1.47M

Sector Composition

Rank Sector Weight
1 Healthcare 9.57%
2 Technology 2.74%
3 Communication Services 2.24%
4 Industrials 2.16%
5 Consumer Discretionary 1.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WGL
26
DELISTED
Wgl Holdings
WGL
$1.53M 0.72%
18,309
+5,000
+38% +$414K
FOR icon
27
Forestar Group
FOR
$1.44B
$1.46M 0.69%
+85,126
New +$1.27M
AZN icon
28
CALL
AstraZeneca
AZN
$263B
$1.36M 0.64%
20,000
-30,000
-60% -$1.96M
WSTC
29
DELISTED
West Corporation
WSTC
$1.33M 0.63%
+57,000
New +$1.36M
UUP icon
30
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$434M
$1.24M 0.58%
50,000
– –
HZNP
31
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.19M 0.56%
+100,000
New +$1.24M
TVTX icon
32
Travere Therapeutics
TVTX
$5.33B
$1.16M 0.55%
60,000
+16,000
+36% +$290K
GLBL
33
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$1.13M 0.53%
223,139
+90,139
+68% +$436K
DIS icon
34
PUT
Walt Disney
DIS
$165B
$1.06M 0.5%
+10,000
New +$1.1M
XLRN
35
DELISTED
Acceleron Pharma
XLRN
$1.05M 0.5%
34,679
+6,709
+24% +$194K
DVY icon
36
iShares Select Dividend ETF
DVY
$24B
$1.01M 0.48%
+11,000
New +$1.01M
FPRX
37
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$989K 0.47%
32,851
+5,651
+21% +$176K
EEM icon
38
iShares MSCI Emerging Markets ETF
EEM
$28B
$898K 0.42%
+21,700
New +$883K
F icon
39
PUT
Ford
F
$57.3B
$895K 0.42%
+80,000
New +$893K
PRXL
40
DELISTED
Parexel International Corp
PRXL
$869K 0.41%
+10,000
New +$745K
RXDX
41
DELISTED
Ignyta, Inc.
RXDX
$864K 0.41%
83,500
+30,011
+56% +$244K
XOM icon
42
CALL
ExxonMobil
XOM
$651B
$807K 0.38%
+10,000
New +$818K
XOM icon
43
PUT
ExxonMobil
XOM
$651B
$807K 0.38%
+10,000
New +$818K
ABUS icon
44
Arbutus Biopharma
ABUS
$865M
$786K 0.37%
218,400
-6,600
-3% -$22.7K
CVS icon
45
CALL
CVS Health
CVS
$137B
$772K 0.36%
9,600
– –
CVS icon
46
PUT
CVS Health
CVS
$137B
$772K 0.36%
9,600
– –
AFMD
47
DELISTED
Affimed
AFMD
$752K 0.35%
36,707
+31,835
+653% +$707K
FATE icon
48
Fate Therapeutics
FATE
$281M
$731K 0.34%
225,700
+75,700
+50% +$290K
SNOW
49
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
$688K 0.32%
+29,000
New +$688K
SNI
50
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$683K 0.32%
+10,000
New +$704K
1
2
3 4 5

Similar funds

SF
SBK Financial Richmond, Virginia $63.1M AUM 17.75% 1-Year Est. Return
CAM
Caprin Asset Management Henrico, Virginia $64.1M AUM 9.09% 1-Year Est. Return
SCFS
S.C. Financial Services Scottsdale, Arizona $65M AUM 9.66% 1-Year Est. Return
LCH
Lee Capital Holdings New York $65.4M AUM 20.44% 1-Year Est. Return
SGMPI
Spark Growth Management Partners II Boston, Massachusetts $66.6M AUM 51.19% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
AI
Abanco Investors Middletown, Rhode Island $57.9M AUM
DFAM
Deep Field Asset Management Beverly Hills, California $57.7M AUM 29.92% 1-Year Est. Return

Telemetry Investments's Q2 2017 Portfolio in Review

As of Q2 2017, Telemetry Investments held 158 positions worth $213M, down 4.5% from $223M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Telemetry Investments withdrew a net $33.9M in Q2 2017, closing 45 positions and reducing 16 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $3.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9.6% of assets, up from 8.2% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Telemetry Investments opened a new position in Alere Inc worth $2.03M.

  • Telemetry Investments's largest Q2 2017 buy was Alere Inc: 40,500 shares worth $2.03M.
  • Telemetry Investments added most to MoneyGram International, Inc. New in Q2 2017, an estimated $2.1M increase.
  • Telemetry Investments's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $1.09M.
  • Telemetry Investments fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $3.37M.
  • Telemetry Investments's ten largest holdings make up 57% of its $213M portfolio in Q2 2017.
  • Telemetry Investments opened 43 new positions and closed 45 in Q2 2017.
  • Telemetry Investments's portfolio value fell 4.5% quarter-over-quarter to $213M.

Based on Telemetry Investments's 13F filing for Q2 2017, filed 14 Aug 2017.